Hims & Hers Health, Inc.
HIMS- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001773751
In the last 90 days, Hims & Hers Health, Inc. insiders filed 0 open-market purchases and 12 sales; 506 institutions reported holding it in 13F filings for Q2 2026, worth $5.41B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsLast 90 days, $6.13M in total
- 12
- 13F holdersQ2 2026, +76 vs. previous quarter
- 506
- 13F valueReported value at the end of Q2 2026
- $5.41B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding HIMS, Q2 2026
No superinvestor reported holding HIMS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Hims & Hers Health, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 (view filing)4:17 PM ET | Sep 22 | 1 day | Okupe OluyemiChief Financial Officer | SSaleClass A Common Stock | −29.3K | $29.95 | −$876.8K | −11.0%236.5K after | 10b5-1 |
| Sep 18, 2026 (view filing)4:17 PM ET | Sep 17 | 1 day | Okupe OluyemiChief Financial Officer | SSaleClass A Common Stock | −12.3K | $28.82 | −$354.9K | −4.7%251.8K after | 10b5-1 |
| Sep 17, 2026 (view filing)4:17 PM ET | Sep 16 | 1 day | Boughton SoleilChief Legal Officer | SSaleClass A Common Stock | −6.24K | $27.86 | −$173.7K | −2.0%304.3K after | 10b5-1 |
| Sep 17, 2026 (view filing)4:17 PM ET | Sep 15 | 2 days | Chi MichaelChief Operating Officer | SSaleClass A Common Stock | −14.0K | $28.39 | −$398.2K | −3.0%456.7K after | 10b5-1 |
| Sep 17, 2026 (view filing)4:17 PM ET | Sep 15 | 2 days | Elshenawy MohamedCTO | SSaleClass A Common Stock | −7.95K | $28.39 | −$225.8K | −4.1%185.6K after | 10b5-1 |
| Sep 3, 2026 (view filing)4:31 PM ET | Sep 2 | 1 day | Boughton SoleilChief Legal Officer | SSaleClass A Common Stock | −3.46K | $28.33 | −$98.0K | −1.1%310.5K after | 10b5-1 |
| Aug 20, 2026 (view filing)4:31 PM ET | Aug 18 | 2 days | Autor Deborah M.Chief Policy Officer | SSaleClass A Common Stock | −16.8K | $27.85 | −$467.1K | −25.5%49.0K after | 10b5-1 |
| Aug 20, 2026 (view filing)4:30 PM ET | Aug 19 | 1 day | Okupe OluyemiChief Financial Officer | SSaleClass A Common Stock | −4.94K | $29.99 | −$148.1K | −1.8%264.1K after | 10b5-1 |
| Aug 20, 2026 (view filing)4:30 PM ET | Aug 19 | 1 day | Boughton SoleilChief Legal Officer | SSaleClass A Common Stock | −25.1K | $27.55 | −$691.8K | −7.4%314.0K after | 10b5-1 |
| Aug 18, 2026 (view filing)5:04 PM ET | Jun 18-Aug 17 | 61 daysLate | Okupe OluyemiChief Financial Officer | SSaleClass A Common Stock | −64.8K | $34.05 | −$2.21M | −19.7%264.1K after | 2 lots10b5-1 |
Top 10 13F holders, Q2 2026
The largest institutional positions in Hims & Hers Health, Inc. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 28,703,514 | $995.2M | 0.01% | +2,366,356+9.0% | Added |
| Vanguard Portfolio Management LLC | 10,559,314 | $366.1M | 0.02% | +375,501+3.7% | Added |
| Vanguard Capital Management LLC | 9,541,384 | $330.8M | 0.01% | +201,673+2.2% | Added |
| State Street Corp | 8,145,699 | $282.4M | 0.01% | +685,676+9.2% | Added |
| Morgan Stanley | 7,152,498 | $248.0M | 0.01% | −1,736,590−19.5% | Reduced |
| Divisadero Street Capital Management, LP | 6,009,505 | $208.3M | 4.86% | +5,539,672+1,179.1% | Added |
| Geode Capital Management, LLC | 5,681,832 | $197.0M | 0.01% | +483,053+9.3% | Added |
| Goldman Sachs Group Inc | 5,173,865 | $179.4M | 0.02% | +2,719,170+110.8% | Added |
| JPMorgan Chase & Co | 4,766,781 | $159.5M | 0.01% | −474,035−9.0% | Reduced |
| FMR LLC | 4,323,292 | $149.9M | 0.01% | +4,230,022+4,535.2% | Added |